董晓武药学院药学· 靶向抗肿瘤药物的设计、合成与抗肿瘤活性研究· 基于结构多样性的化学合成及其在先导化合物发现中的应用· 靶向肿瘤免疫调控的先导化合物发现个人简介:学习经历： 2000.9－2004.6年 浙江大学药学院 药物制剂专业 理学学士 2004.9－2009.6 浙江大学药学院  药物化学 医学博士工作经历： 2009.7 – 2011.6 浙江大学药学院 博士后 2011.7-2014.12 浙江大学药学院 讲师 2011.9-2013.1  香港大学化学系，博士后 2015.1至今  浙江大学药学院 副教授 求是青年学者  教学与课程:担任本科生课程教学：《药物化学》《药物化学实验》《综合药学实验》《药学科研实训》担任研究生课程教学：《高等药物化学》本科生毕业论文设计:    2011级 林森栋 新型Akt抑制剂的设计、合成与活性研究2011级 张敏哲 基于多取代吲哚优势骨架的先导分子设计和发现2010级 张华琛 嘧啶-噻吩类Akt小分子抑制剂的设计、合成研究指导本科生SRTP、国创、省创第22期（2018）浙江大学SRTP项目---金一真、陈祥、庄宇昕国家大学生科技创新项目（2018年）---金一真、庄宇昕第19期（2016）浙江大学SRTP项目---郑佳垚浙江省大学生科技创新项目（2016）---夏凡，赖振成，王凯国家大学生科技创新项目（2015年）--- 朱程远、董俊、胡杭晨第十七期（2014年）浙江大学SRTP--- 沈超，谢家烽，陈紫薇浙江省大学生科技创新项目（2014年） --- 林森栋、张敏哲、邵柏豪第十六期（2013年）浙江大学SRTP项目---林森栋       2014年中国高等教育学会医学教育专业委员会药学教育研究会教改项目  基于移动网络的药化教学资源共享平台建设研究2015年浙江省高等教育课堂教学改革项目云班课在药化交互式教学中的应用       2016年浙江大学教学成果二等奖“互联网+”时代药化课程建设及本科生创新能力培养的探索担任2013级药学3班班主任              获浙江大学蓝田学园2014-2015年度优秀班主任获浙江大学蓝田学园2013-2014年度优秀班主任获浙江大学求是学院2013-2014级年度优秀班主任担任本科生新生之友    2013级药学“新生之友”，被评为优秀“新生之友”2015级新生之友 2015年度浙江大学青年岗位能手荣誉称号2017年度浙江大学优质教学奖二等奖研究与成果:2017:     52. C.-L. Ma  J.-H. Zhao Y. Yang Y; M.K. Zhang C. Shen R. Sheng* X.-W. Dong* Y.-Z. Hu* A Copper-Catalyzed Tandem Cyclization Reaction of Aminoalkynes with Alkynes for the Construction of Tetrahydropyrrolo12-aquinolines Scaffold 2017 7 16640. (IF 4.259)     51. H.-Z. Ying J.-F. Xie X.-G. Liu T.-T. Yao X.-W. Dong* C.-Q. Hu* Discriminatory analysis based molecular docking study for in silico identification of epigallocatechin-3-gallate (EGCG) derivatives as B-Raf V600E inhibitors. RSC Adv. 2017 7 44820–44826.       50. B. Zhang R.-Y. Guo  Y.-Z. Hu  X.-W. Dong  N.-M. Lin  X.-Y. Dai  H.-H. Wu  S.-L. Ma* B. Yang* Design synthesis and biological evaluation of valepotriate derivatives as novel antitumor agents. RSC Adv. 2017 7 31899–31906.       49. C.-Q. Hu K. Li T.-T. Yao Y.-Z. Hu H.-Z. Ying* X.-W. Dong* Integrating docking scores and key interaction profiles to improve the accuracy of molecular docking: towards novel B-Raf V600E inhibitors Med. Chem. Commun. 2017 8 1835–1844.       48. Q. Zhang L. Yan Y. Wu L. Ji Y.C. Chen M.R. Zhao* X.-W. Dong* A ternary classification using machine learning methods of distinct estrogen receptor activities within a large collection of environmental chemicalsSci. Total Environ. 2017 580 1268-1275.       47. T.-T. Yao D.-X. Xiao Z.-S. Li J.-L. Cheng S.-W. Fang Y.-J. Du J.-H. Zhao* X.-W. Dong* G.N. ZhuDesign Synthesis and Fungicidal Evaluation of Novel Pyrazole-furan and Pyrazole-pyrrole Carboxamide as Succinate Dehydrogenase Inhibitors J. Agric. Food Chem. 2017 65 5397-5403.        46. T.-T. Yao S.-W. Fang  Z.-S. Li D.-X. Xiao J.-L. Cheng H.-Z. Ying Y.-J. Du J.-H. Zhao* X.-W. Dong* Discovery of novel succinate dehydrogenase inhibitors by the integration of in silico library design and pharmacophore mapping.  J. Agric. Food Chem. 2017 65 3204–3211.        45. T.-T. Yao J.-F. Xie X.-G. Liu J.-L. Cheng C.-Y. Zhu J.-H. Zhao* and X.-W. Dong* Integration of pharmacophore mapping and molecular docking in sequential virtual screening: towards the discovery of novel JAK2 inhibitors RSC Adv. 2017 7 10353–10360.2016:            44. S.-Y. Wang R. Jin R.-Q. Wang Y.-Z. Hu X.-W. Dong* and A.-E. Xu* The design synthesis and biological evaluation of pro-EGCG derivatives as novel anti-vitiligo agents RSC Adv. 2016 6 106308–106315.43. C.-L. Ma X.-L. Yu X.-L. Zhu Y.-Z. Hu X.-W. Dong* B. Tan* X.-Y. Liu* Gold-Catalyzed Tandem Synthesis of Bioactive Spiro-dipyrroloquinolines and Its Application in the One-step Synthesis of Incargranine B Aglycone and Seneciobipyrrolidine (I) Org. Chem. Front. 2016 3 324-329.2015：42. S.-J. Zhu H.-Z. Ying Y. Wu N. Qiu T. Liu B. Yang X.-W. Dong* Y.-Z. Hu* Design Synthesis and Biological Evaluation of Novel Podophyllotoxin Derivatives Bearing 4β-Disulfide/trisulfide Bond as Cytotoxic Agents RSC advance 2015 5 103172-103183 (IF 3.84).41. X.-M. He X.-W. Dong D.-H. Zou Y. Yu Q.-Y. Fang  Q. Zhang M.-R. Zhao*  Enantioselective Effects of op′-DDT on Cell Invasion and Adhesion of Breast Cancer Cells: Chirality in Cancer Development Environ. Sci. Technol. 2015 4910028-10037 (IF 5.33).40. W.-H. Zhan S.-D. Lin J. Chen X.-W. Dong J.-B. Chu W.T. Du Design Synthesis Biological Evaluation and Molecular Docking of Novel Benzopyran and Phenylpyrazole Derivatives as Akt Inhibitors Chem. Biol. Drug. Des. 2015 85 770–779 (IF 2.50).39. T.-T. Yao J.-L. Cheng B.-R. Xu M.-Z. Zhang G.-N. Zhu Y.-z. Hu J.-H. Zhao* X.-W. Dong* Support Vector Machine (SVM) Classification Model Based Rational Design of Novel Tetronic Acid Derivatives as Potent Insecticidal and Acaricidal Agents RSC advance 2015 5 49195 - 49203 (IF 3.84). 38. C.-L. Ma X.-L. Yu X. Zhu Y.-Z. Hu Y. X.-W. Dong* B. Tan* X.-Y. Liu* Platinum-Catalyzed Tandem Cyclization Reaction to Multiply Substituted Indolines under Microwave-Assisted Conditions. Adv. Synth. Catal. 2015 357 (2) 569-575 (IF 5.66). 2014：37. S. -W. Hu Q. Gu Z. Wang Z. Weng Y. Cai X.-W. Dong Y.-Z. Hu T. Liu* X. Xie* Design synthesis and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors. Eur J Med Chem 2014 71 259-66 (IF 3.45).36. Q. Zhang M. Lu X.-W. Dong C. Wang C. Zhang W.  Liu M. Zhao* Potential estrogenic effects of phosphorus-containing flame retardants. Environ. Sci. Technol. 2014 48 6995-7001 (IF 5.33).35. T. Liu C.-X. Che Y.-Z. Hu X.-W. Dong* X.-Y. Liu* C.-M. Che Alkenyl/Thiol-Derived Metal-Organic Frameworks (MOFs) by Means of Postsynthetic Modification for Effective Mercury Adsorption. Chem-Eur. J. 2014 20 (43) 14090-5 (IF 5.73).34. T. Liu D.-Q. Li S.Y. Wang Y.-Z. Hu W.-W. Dong* X.-Y. Liu* C.M. Che Straightforward installation of carbon-halogen carbon-oxygen and carbon-carbon bonds within metal-organic frameworks (MOF) via palladium-catalysed direct C-H functionalization. Chem Commun (Camb) 2014 50 (87) 13261-4 (IF 6.83) Highlighted by synfacts.33. W.-H. Zhan D.-Q.Li J.-X. Che L. Zhang B. Yang Y.-Z. Hu T. Liu X.-W. Dong* Integrating docking scores interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors. Eur J Med Chem 2014 75 11-20 (IF 3.45).32. T. Liu T. W.-H. Zhan Y.-M. Wang L. Zhang B. Yang X.-W. Dong* Y.-Z. Hu* Structure-based design synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors. Eur J Med Chem 2014 73 167-76 (IF 3.45).2013：31. X. -W. Dong T. Liu Y.-Z. Hu* X.-Y. Liu C. -M. Che Urea postmodified in a metal-organic framework as a catalytically active hydrogen-bond-donating heterogeneous catalyst. Chem Commun (Camb) 2013 49 (70) 7681-3 (IF 6.83) inside cover picture Highlighted by synfacts.30. T. Liu Z. Y. Weng X.-W. Dong L. Chen L. Ma S. Cen N. Zhou Y.-Z. Hu* Design synthesis and biological evaluation of novel piperazine derivatives as CCR5 antagonists. PLoS One 2013 8 (1) e53636 (IF 3.23).29. X. –W. Dong Y. M. Zhao X.-Q. Huang K. -N. Lin J. Chen E.-Q. Wei T. Liu Y.-Z. Hu Structure-based drug design using GPCR homology modeling: Toward the discovery of novel selective CysLT2 antagonists. Eur J Med Chem 2013 62 754-63 (IF 3.45).2012：28. X.-W. Dong J.-Y. Yan L.-L. Du P. Wu S.-F. Huang T. Liu Y.-Z. Hu* Pharmacophore identification docking and "in silico" screening for novel CDK1 inhibitors. J Mol Graph Model 2012 37 77-86 (1.72).27. X.-W. Dong; J.-Y. Yan D. Lu P. Wu J.-D. Gao T. Liu B. Yang Y.-Z. Hu* QSAR models for isoindolinone-based p53-MDM2 interaction inhibitors using linear and non-linear statistical methods. Chem Biol Drug Des 2012 79 (5) 691-702 (IF 2.50).26.  S. -F. Huang Y. M. Zhao X.-L. Zhou Y. -Z. Wu P. Wu T. Liu B. Yang Y.-Z. Hu X. -W. Dong* Design synthesis and biological evaluation of 3-benzylideneflavanone derivatives as cytotoxic agents. Med Chem Res 2012 21 (12) 4150-4157 (IF 1.40).25. Z. Y. Weng W. Wei X.-W. Dong Y.-Z. Hu S. -F. Huang T. Liu* X. Xie Synthesis and biological evaluation of novel piperidin-4-ol derivatives. Monatsh Chem 2012 143 (2) 303-308 (IF 1.22).24. P. Wu Y. Su X. Guan X.-W. Liu J. Zhang X.-W. Dong W.-H. Huang Y.-Z. Hu Identification of novel piperazinylquinoxaline derivatives as potent phosphoinositide 3-kinase (PI3K) inhibitors. PLoS One 2012 7 (8) e43171 (IF 3.23).23. P. Wu Y. Su X.-W. Liu J.-Y. Yan Y. Ye L. Zhang J. -C. Xu S.-Y. Weng Y. N. Li T. Liu X.-W. Dong M. T. Sun B. Yang Q. J. He Y. –Z. Hu* Discovery of novel morpholino-quinoxalines as PI3K alpha inhibitors by pharmacophore-based screening. Medchemcomm 2012 3 (6) 659-662 (IF 2.45).   2011：22. X.-W. Dong Y. Wang T. Liu P. Wu J.-D. Gao J. Xu B. Yang Y.-Z. Hu*      Flavonoids as vasorelaxant agents: synthesis biological evaluation and      quantitative structure activities relationship (QSAR) studies. Molecules 2011 16 8257-72 (IF 2.42).21. X.-W. Dong X.-L. Zhou H. Jing J. Chen T. Liu B. Yang Q.-J. He Y.-Z. Hu*      Pharmacophore identification virtual screening and biological evaluation      of prenylated flavonoids derivatives as PKB/Akt1 inhibitors. Eur. J.      Med. Chem. 2011 46      5949-58 (IF 3.45).20. C. -Q. Hu X. Li W. Wang L. Zhang L. Tao X.-W. Dong R. Sheng B. Yang Y.-Z Hu* Design synthesis and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors. Bioorg Med Chem 2011 19 5454-61 (IF 2.79).19. C. Zhang T.-Y. Cai H. Zhu L.-Q. Yang H. Jiang X.-W. Dong Y.-Z. Hu N. -M. Lin Q.-J. He B. Yang Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1. Mol Cancer Ther 2011 10 1264-75 (IF 5.68).18. J. Chen T. Liu R. Wu J.-S. Lou X.-W. Dong Q. -J. He B. Yang Y.-Z. Hu Design synthesis and biological      evaluation of novel gamma-carboline ketones as anticancer agents. Eur. J. Med. Chem. 2011 46 1343-1347 (IF 3.45).2010：17. X.-W. Dong L. Wang X.-Q. Huang T. Liu E.-Q. Wei L.-L. Du B. Yang Y.-Z. Hu* Pharmacophore identification synthesis and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonists Bioorg. Med. Chem. 2010 18 5519-5527 (IF 2.79).16. H. Jing X.-L. Zhou X.-W. Dong J. Cao H. Zhu J. Shu Y.-Z. Hu Q.-J. He B. Yang Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells. Cancer Lett. 2010 294 167-177 (IF 5.62).15. X.-W. Dong L.-L. Du Z.-C. Pan T. Liu B. Yang Y.-Z. Hu* Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents  Eur. J. Med. Chem.  2010 45 3986-3992 (IF 3.45).2009：14. X.-W. Dong T. Liu J.-Y. Yan P. Wu J. Chen Y.-Z. Hu* Synthesis Biological Evaluation and Quantitative Structure-Activities Relationship of Flavonoids as Vasorelaxant Agents. Bioorg. Med. Chem. 2009 17 716-726 (IF 2.79). 13. X.-W. Dong L.-L Qi C.-Y. Jiang J. Chen E.-Q. Wei Y.-Z. Hu* Synthesis Biological Evaluation of Prenylflavonoids as Vasorelaxant and Neuroprotective Agents. Bioorg. Med. Chem. Lett. 2009 19 3196-3198 (2.42).12. X.-W. Dong C.-Y. Jiang H.-Y. Hu J.-Y. Yan J. Chen Y.-Z. Hu* QSAR Study of Akt/Protein Kinase B (PKB) Inhibitors Using Support Vector Machine. Eur. J. Med. Chem. 2009 44 4090-4097 (IF 3.45).11. X.-W. Dong T. Liu Y.-P. Gao J. Chen Y.-Z. Hu* One-pot Synthesis of 3-Benzylflavones Synth. Commun. 2009 39 7-742.10. X.-W. Dong T. Liu J. Chen H.-Z. Ying Y.-Z. Hu* Microwave-Assisted Mannich Reaction of 2-Hydroxy-Chalcones Synth. Commun. 2009 39 733-742. 9. X.-W. Dong J. Chen C.-Y. Jiang T. Liu Y.-Z. Hu* Design Synthesis and Biological Evaluation of Prenylated Chalcones as Vasorelaxant Agents Arch. Pharm. 2009 342 428-4328. J. Chen X.-W. Dong T. Liu J.-S. Lou C.-Y. Jiang W.-H. Huang Q.-J. He B. Yang Y.-Z. Hu* Design Synthesis and Quantitative Structure-Activitiy Relationship of Cytotoxic γ-Carboline Derivatives Bioorg. Med. Chem. 2009 17 3324-3331 (IF 2.79). 7. J. Chen T. Liu X.-W. Dong Y.-Z. Hu*. Recent development of colchicine binding site inhibitors. Mini-Reviews in Medicinal Chemistry 2009 9 (10) 1174-1190 (IF 2.90).6. Y.-H. Shen J. Zhang R. Sheng X.-W. Dong Q.-J. He B. Yang Y.-Z. Hu* Synthesis and biological evaluation of novel flavonoids derivatives as dual binding acetylcholinesterase inhibitors. J. Enzyme Inhib. Med. Chem. 2009 24 372-380.5. J. Chen J.-S. Lou T. Liu R. Wu X.-W. Dong Q.-J. He B. Yang Y.-Z. Hu* Synthesis and in-vitro Antitumor Activities of some Mannich Bases of 9-Alkyl-1234-Tetrahydrocarbazole-1-ones. Arch. Pharm. 2009 342 3165-172. 4. T. Liu X.-W. Dong N. Xue R. Wu Q.-J. He B. Yang Y.-Z. Hu* Synthesis and biological evaluation of 34-diaryl-5-aminoisoxazole derivatives. Bioorg. Med. Chem. 2009 17 6279 – 6285 (IF 2.79).3. T. Liu  M.-T. Sun X.-W Dong X. Ren X. Yang L.-L Du Y.-Z. Hu* Structure-Based Drug Design Synthesis and Antitumor Activities of Novel CDK7 Inhibitors. Acta. Physico-chimica Sinica 2009 25 (10) 2107-2112.2008：2. X.-W Dong Y.-J. Liu J.-Y. Yan C.-Y. Jiang J. Chen T. Liu Y.-Z. Hu* Identification of SVM-based classification model synthesis and evaluation of prenylated flavonoids as vasorelaxant agents Bioorg. Med. Chem. 2008 16 8151-8160 (IF 2.79).2007：1. X.-W Dong Y.-J. Fan L.-J. Yu Y.-Z. Hu* Synthesis of Four Natural Prenylflavonoids and their Estrogen-like activities. Arch      Pharm. 2007 340 372-376.  科研:靶向蛋白酶体的Best-in-class创新药物E83的系统临床前任务 “重大新药创制”科技重大专项（2018ZX09711002-011-022）新型AKT抑制剂Hu7691、Hu7151抗肿瘤新药的临床前研究任务 “重大新药创制”科技重大专项 （2018ZX09711002-011-023）基于靶向蛋白降解嵌合分子（PROTACs）策略的新型Akt蛋白降解功能分子的设计、合成及抗肿瘤活性评价， 中科院上海药物研究所新药研究国家重点实验室， 开放研究课题（SIMM1705KF-08）新型E3泛素连接酶WSB-1抑制剂的设计、合成和抗肿瘤转移活性研究，国家自然基金面上项目（81673294） “吡唑苯环类Akt-Braf双靶点抑制剂的设计、合成和抗肿瘤活性研究”， 浙江省科技厅公益性项目（2016C33067）“新型吡唑-呋喃类Akt抑制剂设计、合成和生物活性评价”，浙江省自然科学基金（LY13H300002）“基于靶标结构的新型Akt抑制剂的设计、合成和抗肿瘤活性研究”中国博士后基金一等资助（20090460103）“类黄酮衍生物的心血管保护作用及类药性评价”浙江省医药卫生科学研究基金计划(2010KYA061)“ 苯并吡喃酮类Akt抑制剂的设计、合成以及抗肿瘤活性研究”，国家自然科学基金（青年基金81001359）“苯并吡喃酮类Akt抑制剂的设计、合成以及抗肿瘤活性研究”中国博士后基金特别资助（201003734）“基于靶标结构的苯并吡喃酮类Akt抑制剂的设计、合成和抗肿瘤活性研究”天然药物及仿生药物国家重点实验室（北京大学）开放基金课题编号（K20100108）“p53-MDM2和Akt酶双靶点抑制剂的设计、合成和抗肿瘤活性研究”浙江省教育厅科研项目（Y201018915，参与）   “新型哌嗪类CCR5拮抗剂的设计、合成和抗HIV活性研究” 国家自然科学基金（81072515，参与） 专利:PCT专利： 1. 取代氮杂环类衍生物、含其的药物组合物及其在抗肿瘤中的应用PCT/CN2015/074813中国专利：9. 多氟取代芳联杂环类衍生物、含其的药物组合物及其应用 2017100553576.88.一类缬草素衍生物、含其的药物组合物及其在抗肿瘤中的应用， 201610116022.37. 蛋白酶体抑制剂Oprozomib及其类似物的制备方法， 201610273652.16. 一种铜催化的含氮多杂环化合物的制备方法，201610265584.45. 4-αβ不饱和酰胺基喹啉类化合物及制备和应用， 201510340374.24. 34-二取代-6-吡啶基喹啉类化合物及制备和应用， 201510619979.53. 取代氮杂环类衍生物、含其的药物组合物及其在抗肿瘤中的应用 201410124591.32. 取代哌啶类衍生物、含其的药物组合物及其在抗肿瘤中的应用 201510101220.81. 含羧基取代的查耳酮类衍生物及制备方法和用途 ZL200810122374.5其他:出版论著:参编《药物设计学学习指导与习题集》 第2版 杨晓虹 主编 药学类专业用 药学专业第八轮规划教材配套参编《药物设计学》数字化教材 人民卫生出版社学术兼职：国家自然科学基金、省自然科学基金评审专家现代应用药学杂志青年编委Arch pharm、EJMC、BMC等杂志审稿人